<DOC>
	<DOCNO>NCT02630992</DOCNO>
	<brief_summary>To evaluate safety profile amoxicillin-clavulanate potassium contain reduce concentration clavulanate potassium , 600 mg/21.5 mg/5 mL ( ratio 28:1 ) , administer 90/3.2 mg/kg/day two divide dos 10 day . Investigators focus proportion subject develop protocol-defined diarrhea proportion develop diaper dermatitis occasion prescription antifungal medication .</brief_summary>
	<brief_title>Reduced Clavulanate Formulation Amoxicillin-Clavulanate Children 6-23 Months With Acute Otitis Media</brief_title>
	<detailed_description>Amoxicillin-clavulanate potassium show efficacious eradicate causative pathogen acute otitis medium ( AOM ) result high clinical cure rate end-of-treatment ( 85 % ) . However , relatively high rate ( ~25 % ) clinically significant diarrhea report , occurrence directly relate clavulanate potassium component drug combination . A reduced concentration clavulanate potassium drug formulation would expect improved safety profile regard occurrence diarrhea . This study examine whether concentration clavulanate potassium component amoxicillin-clavulanate potassium could reduce treatment child 6 month 23 month age diagnose AOM use stringent criterion . A total 75 participant ( n=75 ) AOM receive amoxicillin-clavulanate potassium ( 600 mg/21.5 mg/5 mL ; 28:1 ) administer 90/3.2 mg/kg two divide dos 10 day . The primary outcome measure rate clinically significant diarrhea diaper dermatitis . These rate compare rate observe previous study AOM child receive amoxicillin-clavulanate potassium ( 600 mg/42.9 mg/5 mL ; 14:1 ) administer 90/6.4 mg/kg two divide dos 10 day . A subset group pharmacokinetic study perform . Each participant agree single blood draw ( n=50 ) . Investigators analyze amoxicillin clavulanate potassium blood sample use validated method .</detailed_description>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Age range : 6 23 month Evidence AOM Recent ( within 48 hour ) onset sign symptom . Middle ear effusion evidence presence least 2 follow : decrease absent mobility TM , yellow white discoloration TM ( tympanic membrane ) , and/or opacification TM Acute inflammation evidence one following : 1+ bulge TM either intense erythema otalgia 2+ 3+ bulge TM Toxic appearance ( capillary refill &gt; 3 second , systolic blood pressure &lt; 60 mm Hg ) Inpatient hospitalization Clinical anatomical characteristic might obscure response treatment ( e.g. , tympanostomy tubes place , cleft palate , Down syndrome ) Sensorineural hearing loss ( unilateral bilateral ) Allergy amoxicillin amoxicillin clavulanate Recent treatment AOM within last 14 day</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>23 Months</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>ear infection</keyword>
	<keyword>antibiotic</keyword>
	<keyword>antibiotic resistance</keyword>
	<keyword>pediatrics</keyword>
	<keyword>infant</keyword>
	<keyword>child</keyword>
	<keyword>amoxicillin-clavulanate</keyword>
</DOC>